ENTITY

Caliway Biopharmaceuticals (6919 TT)

48
Analysis
Health Care β€’ Taiwan
Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.
more
bullishβ€’Hon Precision
β€’05 Jan 2026 16:33

Quiddity Leaderboard T50/​​​100 Mar26: Couple of TDIV Deletions Likely as Things Stand

When TDIV members get deleted from the T100 index, they get deleted from the TDIV index too which triggers major index outflows for those stocks....

Share
bullishβ€’Chroma Ate Inc
β€’13 Nov 2025 06:30

Taiwan Top 50 ETF Rebalance Preview: Plenty of Big Overlapping Flows Coming Up

We currently forecast 4 changes for the ETF in Dec. That could increase to 5. Multiple stocks will have same-way flow from other index trackers...

Logo
714 Views
Share
β€’08 Sep 2025 17:04

Quiddity T50/100/DIV Sep25 Results: 100% Hit Rate; M&A DEL King's Town to Trigger Intra-Review Flows

We expect US$866mn one-way flows for the TDIV index. There are few high-impact names with more than 3x ADV to trade. Some of the high-impact names...

Share
β€’07 Sep 2025 07:43

Taiwan Top 50 ETF Rebalance: Another Inclusion for Caliway Biopharma & King Slide

Caliway Biopharma and King Slide are adds at the close on 19 Sep. Both stocks were added to a global index end August and Caliway has another...

Logo
771 Views
Share
β€’26 Aug 2025 05:30

Taiwan Top 50 ETF Rebalance Preview: Hat Trick for Caliway Biopharma?

There could be 2 changes for the ETF in Sep. Caliway and King Slide are inclusions to a global index at the close today. Passive trackers of...

Logo
631 Views
Share
x